BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Bio NC

  Chelsea Therapeutics, Inc. to Present at Leerink Swann and Company 2012 Global Healthcare Conference

  February 16, 2012

   · 

  1 min read
• Deals

  Sandoz, Inc. Buys German Rights to Apricus Biosciences’ Sex Drug for $28 Million

  February 16, 2012

   · 

  5 min read
• Policy

  GlaxoSmithKline Withdraws Application for Wider Tyverb Use

  February 16, 2012

   · 

  1 min read
• Policy

  Merck KGaA Receives Highly Unusual, Holistic Warning Letter From FDA

  February 16, 2012

   · 

  1 min read
• Business

  Johnson & Johnson to Develop Spider Venom Pain Drug With Queensland University

  February 16, 2012

   · 

  1 min read
• Genetown

  Sanofi (France)'s Genzyme Corporation Recalls 9,380 Vials of Fludara Leukemia Drug Made at Ben Venue Laboratories Plant

  February 16, 2012

   · 

  1 min read
• Business

  GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development

  February 16, 2012

   · 

  1 min read
• Business

  Biocryst Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results

  February 16, 2012

   · 

  1 min read
• BioMidwest

  BioSante Pharmaceuticals, Inc. Exchanges $4 Million Aggregate Principal Amount of Convertible Senior Notes for 4.5 Million Shares of Common Stock

  February 16, 2012

   · 

  1 min read
• FDA

  China’s SFDA Approves Affymetrix (Santa Clara, California) GeneChip System 3000Dx v.2

  February 16, 2012

   · 

  4 min read